Patents by Inventor Aubrey Jones

Aubrey Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050048619
    Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Application
    Filed: August 25, 2004
    Publication date: March 3, 2005
    Applicant: Novozymes Biotech, Inc.
    Inventors: Sarah Teter, Joel Cherry, Connie Ward, Aubrey Jones, Paul Harris, Jung Yi
  • Patent number: 6528317
    Abstract: A method of providing a detectable marker in a fluid. The method comprises disposing in said fluid a marker composition 10 comprising a matrix material 12 having a detectable marker substance 14 incorporated therein, the matrix material 12 serving to release the marker substance 14 into the fluid over time.
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: March 4, 2003
    Assignee: Wrc plc
    Inventors: Gerald Frank Moss, Gerald Melville Aubrey Jones
  • Patent number: 6306630
    Abstract: The present invention relates to Aspergillus porphobilinogen synthases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the porphobilinogen synthases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods of producing the porphobilinogen synthases.
    Type: Grant
    Filed: September 30, 1998
    Date of Patent: October 23, 2001
    Assignee: Novozymes Biotech, Inc.
    Inventors: Aubrey Jones, Joel R. Cherry
  • Patent number: 6261827
    Abstract: The present invention relates to methods of producing hemoproteins comprising (a) introducing into a filamentous fungal cell, which is capable of producing the hemoprotein, (i) one or more first control sequences capable of directing the expression of a heme biosynthetic enzyme encoded by a first nucleic acid sequence endogenous to the filamentous fungal cell, wherein the one or more of the first control sequences are operably linked to the first nucleic acid sequence; and/or (ii) one or more copies of one or more second nucleic acid sequences encoding a heme biosynthetic enzyme; (b) cultivating the filamentous fungal cell in a nutrient medium suitable for production of the hemoprotein and the heme biosynthetic enzymes; and (c) recovering the hemoprotein from the nutrient medium of the filamentous fungal cell.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: July 17, 2001
    Assignee: Novozymes Biotech, Inc.
    Inventors: Susan L. Elrod, Joel R. Cherry, Aubrey Jones
  • Patent number: 6100057
    Abstract: The present invention relates to methods of producing hemoproteins comprising (a) introducing into a filamentous fungal cell, which is capable of producing the hemoprotein, (i) one or more first control sequences capable of directing the expression of a heme biosynthetic enzyme encoded by a first nucleic acid sequence endogenous to the filamentous fungal cell, wherein the one or more of the first control sequences are operably linked to the first nucleic acid sequence; and/or (ii) one or more copies of one or more second nucleic acid sequences encoding a heme biosynthetic enzyme; (b) cultivating the filamentous fungal cell in a nutrient medium suitable for production of the hemoprotein and the heme biosynthetic enzymes; and (c) recovering the hemoprotein from the nutrient medium of the filamentous fungal cell.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: August 8, 2000
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: Susan L. Elrod, Joel R. Cherry, Aubrey Jones
  • Patent number: 5993114
    Abstract: A method of providing an internal lining in a pipeline. The method comprises inverting a tubular liner within said pipeline, said liner having a cementitious coating on a surface thereof. This brings the cementitious material into contact with the wall of the pipeline.
    Type: Grant
    Filed: January 7, 1998
    Date of Patent: November 30, 1999
    Assignee: WRC PLC
    Inventor: Gerald Melville Aubrey Jones
  • Patent number: 5866391
    Abstract: The present invention relates to Aspergillus porphobilinogen synthases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the porphobilinogen synthases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods of producing the porphobilinogen synthases.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: February 2, 1999
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: Aubrey Jones, Joel R. Cherry
  • Patent number: 5723761
    Abstract: This invention relates to plant thioesterases, specifically plant acyl-ACP thioesterases having substantial activity on palmitoyl-ACP substrates. DNA constructs useful for the expression of a plant palmitoyl-ACP thioesterase in a plant seed cell are described. Such constructs will contain a DNA sequence encoding the plant palmitoyl-ACP thioesterase of interest under the control of regulatory elements capable of preferentially directing the expression of the plant palmitoyl-ACP thioesterase in seed tissue, as compared with other plant tissues, when such a construct is expressed in a transgenic plant. This invention also relates to methods of using a DNA sequence encoding a plant palmitoyl-ACP thioesterase for the modification of the proportion of free fatty acids produced in a plant seed cell. Plant palmitoyl-ACP thioesterase sequences exemplified herein include Cuphea, leek, mango and elm.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: March 3, 1998
    Assignee: Calgene, Inc.
    Inventors: Toni A. Voelker, Ling Yuan, Jean Kridl, Deborah Hawkins, Aubrey Jones